Find Research Projects

Search results

• Federal Funding Agencies

  NY-ESO-1-specific TCR-engineered T cell immunotherapy for triple negative breast cancer

  Wang, R. & Chang, J. C.

  9/30/16 → 10/28/19

  Project: Federal Funding Agencies

• The role of the gut microbiome in the neuropathology of traumatic brain injury

  Villapol, S. & Kumaraswami, M.

  10/1/18 → 3/31/22

  Project: Federal Funding Agencies

• Multimodal MRI Biomarker of Mild Cognitive Impairment in Breast Cancer

  Niravath, P. A., Chang, J. C. & Darcourt, J.

  9/26/16 → 6/30/18

  Project: Federal Funding Agencies

• Carotid Revascularization and Medical Management for Asymptomatic Carotid stenosis - Hemodynamics (CREST-H)

  Chiu, D., Gadhia, R. R., Misra, V. & Volpi, J. J.

  5/15/17 → 4/30/22

  Project: Federal Funding Agencies

• The University of Texas M.D. Anderson Cancer Center SPORE in Hepatocellular Carcinoma

  Cristini, V.

  9/1/20 → 8/31/24

  Project: Federal Funding Agencies

• EPIGENETIC REPROGRAMMING TO GENERATE NOVEL CHONDRO-OSSEOUS STEM CELLS FOR BONE TISSUE ENGINEERING

  Davis, B.

  7/15/20 → 6/30/22

  Project: Federal Funding Agencies

• Systematic modeling and prediction of cell-type-specific and spatiotemporal crosstalk pathways in Alzheimer¿s Disease

  Wong, S. T., Sheng, J. & Yin, Z.

  5/15/21 → 4/30/26

  Project: Federal Funding Agencies

• A Novel M2 Lipogenic Macrophage Associated with Fracture Callus are Altered in Type 2 Diabetes

  Davis, B.

  6/1/21 → 5/31/23

  Project: Federal Funding Agencies

• The immunosuppressive function of secretory IgM in tumor-bearing mice

  Tang, C. A. & Yin, Z.

  6/1/21 → 5/31/24

  Project: Federal Funding Agencies

• AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer¿s Disease and Inter Amyloid (A3 Trial)

  Masdeu, J. C., Faridar, A. & Nakawah, M. O.

  6/1/19 → 4/30/22

  Project: Federal Funding Agencies

• Determinants of COVID19-induced venous thrombosis and targeted therapy assessed with bioengineered Vein-Chip.

  Cooke, J. P.

  5/1/21 → 4/30/25

  Project: Federal Funding Agencies

• Contemporary Classification of Myocardial Injury Events in MESA: Defining Distinct Risk Factor Associations with Myocardial Infarction Type 1-5 and Acute Non-Ischemic Myocardial Injury.

  Nasir, K.

  8/20/21 → 7/31/26

  Project: Federal Funding Agencies

• Harnessing neuroplasticity of postural sensorimotor networks using non-invasive spinal neuromodulation to maximize functional recovery after spinal cord injury

  Sayenko, D., Barber, S., Horner, P. J., Kaldis, T. & Vahidy, F. S.

  12/1/21 → 11/30/26

  Project: Federal Funding Agencies

• Role of integrin VLA-6 in suppression of bone formation in myeloma

  Yang, J.

  2/1/20 → 1/31/23

  Project: Federal Funding Agencies

• Transforming triple negative breast cancer treatment through intratumoral immunotherapy via nanofluidic drug eluting seed

  Chen, S. & Chang, J. C.

  8/1/20 → 7/31/23

  Project: Federal Funding Agencies

• Understanding the mechanisms that regulate cytoplasmic capping and defining its contributions to post-transcriptional gene regulation

  Kiss, D. L.

  8/15/20 → 6/30/25

  Project: Federal Funding Agencies

• Targeting adipocyte-secreted chemerin for chemotherapy resistance in myeloma

  Yang, J.

  1/1/20 → 6/30/22

  Project: Federal Funding Agencies

• Systematic identification of astrocyte-tumor crosstalk regulating brain metastatic tumors

  Wong, S. T., Zhao, H. & Sheng, J.

  8/1/20 → 1/31/25

  Project: Federal Funding Agencies

• Novel Determinants of Streptococcus Pyogenes Virulence and Protective Immunity in the Primate Oropharynx: A Genome-wide Strategy

  Musser, J. M., Nagueh, S., Olsen, R. J. & Zhu, L.

  6/1/21 → 5/31/22

  Project: Federal Funding Agencies

• TB/MDR-TB research Capacity Building in LMIC in Southeast Asia

  Graviss, E. A.

  4/1/21 → 3/31/22

  Project: Federal Funding Agencies

• Development of predictive model and social determinants-based interventions for aggressive prostate cancer among African American males

  Esnaola, N. F., Jones, S. L. & Satkunasivam, R.

  9/30/20 → 9/29/22

  Project: Federal Funding Agencies

• FDP Sub in - MESENCHYMAL STEM CELLS FOR THE TREATMENT OF MODERATE TO SEVERE COVID-19 ACUTE RESPIRATORY DISTRESS SYNDROME

  Zainab, A., Hsu, S. H., Masud, F. N. & Reardon, M. J.

  3/1/20 → 2/28/22

  Project: Federal Funding Agencies

• AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial)

  Masdeu, J. C., Faridar, A. & Nakawah, M. O.

  9/30/19 → 5/31/22

  Project: Federal Funding Agencies

• Nanozyme Therapy for Chronic Venous Stasis Dermatitis: New Approach for a Major Unmet Clinical Need

  Cooke, J. P.

  4/1/21 → 3/31/23

  Project: Federal Funding Agencies

• Remote controlled nanochannel implant for tunable drug delivery

  Grattoni, A.

  7/1/20 → 10/1/21

  Project: Federal Funding Agencies

• Supraspinal mechanisms involved in neurogenic voiding dysfunction

  Khavari, R., Boone, T. B., Helekar, S. & Karmonik, C.

  8/1/20 → 7/31/22

  Project: Federal Funding Agencies

• Recovery and Outcomes from Stroke-Longitudinal Assessment With Neuroimaging

  Vahidy, F. S.

  12/15/20 → 11/30/21

  Project: Federal Funding Agencies

• Effects of Thyroid Hormone Metabolite Treatment for Postmenopausal Heart Repair

  Filgueira, C. S., Bhimaraj, A. & Youker, K. A.

  12/1/21 → 11/30/23

  Project: Federal Funding Agencies

• Upper Extremity Nerve Transfers in Spinal Cord Injury Patients

  Faraji, A.

  5/1/21 → 9/29/22

  Project: Federal Funding Agencies

• Elucidate the effect of biophysical properties evolution in sentinel lymph node of breast cancer on initiating lung metastasis using novel ultrasound poroelastography

  Liu, X.

  2/1/21 → 1/31/22

  Project: Federal Funding Agencies

• Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer

  Hu, A.

  8/1/21 → 7/31/22

  Project: Federal Funding Agencies

• EGFR and KRAS Vaccine to Prevent Lung Cancer

  Wang, Y. & You, M.

  5/10/21 → 11/30/22

  Project: Federal Funding Agencies

• Potentiation of Multi-peptide Lung Cancer Vaccines with Immune Checkpoint Antagonist CA-170

  You, M. & Yi, Q.

  5/24/21 → 11/23/23

  Project: Federal Funding Agencies

• RE-ENERGIZE FONTAN - RandomizEd Exercise INtERvention desiGned to MaximIZE Fitness in Pediatric FONTAN patients

  Cooke, J. P.

  3/26/21 → 2/28/25

  Project: Federal Funding Agencies

• Children's Oncology Group

  Chévez-Barrios, P.

  National Childhood Cancer Foundation

  3/1/06 → 2/28/12

  Project: Federal Funding Agencies

• High content Image Analysis and Modeling for Neuron Assay Based Screening

  Wong, S. T.

  National Institute on Aging

  9/15/07 → 7/2/12

  Project: Federal Funding Agencies

• B-cell depletion by anti-CD20 (Rituximab) in renal allograft recipients who develop de novo anti-HLA allo-antibodies will result in inhibition of allo-antibody production and attenuation of chronic humoral rejection

  Gaber, A. O.

  Brigham and Women's Hospital

  9/1/07 → 8/31/09

  Project: Federal Funding Agencies

• Assessing QFT as an Initial Screening Tool for U.S.-Bound Applicants for Immigration and Feasibility of Follow-up in U.S. Immigrants

  Graviss, E. A.

  Denver Health and Hospital Authority

  12/5/08 → 9/27/11

  Project: Federal Funding Agencies

• 2009-030442-001 Tuberculosis Elimination

  Graviss, E. A.

  Texas Dept of State Health Services

  12/12/08 → 9/30/11

  Project: Federal Funding Agencies

• Improving the Utilization and Integrationof TB Genotyping into Routine TB Program Practice: Analyzing the Impact through Public Health Interventions

  Graviss, E. A.

  Texas Dept of State Health Services

  12/12/08 → 9/30/11

  Project: Federal Funding Agencies

• PhosphodiesteRaseE-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure Study

  Kurrelmeyer, K. M.

  Baylor College of Medicine

  8/28/09 → 12/31/12

  Project: Federal Funding Agencies

• Single-molecule nanomagnetic assays for ultrasmall sample clinical diagnostics

  Zu, Y.

  9/24/09 → 8/31/11

  Project: Federal Funding Agencies

• Genetic Modulation of Left Ventricular Recovery (University of Pittsburgh Reference Number 108216)

  Torre-Amione, G.

  University of Pittsburgh

  12/1/05 → 12/31/06

  Project: Federal Funding Agencies

• Evaluation of New Interferon Gamma Release Assays in the Diagnosis of Latent Tuberculosos Infection in Healthcare Workers

  Graviss, E. A.

  Texas Dept of State Health Services

  8/1/08 → 9/30/10

  Project: Federal Funding Agencies

• Carotid Occlusion Surgery Study (COSS)

  Volpi, J. J.

  University of North Carolina-Chapel Hill

  8/5/09 → 11/30/12

  Project: Federal Funding Agencies

• Development of a point-of-care volumetric bar-chart chip for drug quantitation

  Qin, L.

  National Institute on Drug Abuse

  7/15/13 → 5/31/17

  Project: Federal Funding Agencies

• Immune Monitoring and CNI Withdrawl in Low Risk Recipients of Kidney Transplantation (CTOT-09).

  Gaber, A. O.

  Mount Sinai School of Medicine

  4/1/12 → 8/31/14

  Project: Federal Funding Agencies

• Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter - Directed Thrombolysis-ATTRACT Trial

  Peden, E. K.

  Washington University

  2/26/10 → 3/31/11

  Project: Federal Funding Agencies

• Expression of Diagnostic and Prognostic Markers of Hematological Disorders

  Zu, Y.

  University of Houston

  9/15/10 → 7/31/13

  Project: Federal Funding Agencies

• Role of Pancytopenia and inflammatory Signaling in the Mechanism of AIRE-Induced Microvascular and Organ Damage Using an Animal Imaging Model.

  Sabek, O.

  Baylor College of Medicine

  7/13/10 → 4/4/14

  Project: Federal Funding Agencies